Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
178 participants
OBSERVATIONAL
2010-11-30
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of a Specific Substance in Smokers
NCT04281979
Smokers' Health Project: Self-Determination and Maintaining Tobacco Abstinence
NCT00178685
Project 1, Study 2: The Combined Impact of Nicotine Replacement and Spectrum Cigarettes
NCT02301325
Proactive Health Intervention for Tobacco Users (Get PHIT)
NCT00169260
EEG & Behavioral Predictors of Changes in Smoking Trajectories in Young Light Smokers
NCT02129387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Heavy smokers, 15 or more cigarettes/day
Nicotine dependent.
No interventions assigned to this group
Light smokers (chippers)
Less than 2 cigarettes/day, at least 2 days/week. Non nicotine-dependent.
No interventions assigned to this group
Non smokers
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 25-55
Exclusion Criteria
* unstable significant medical problems
* neurologic disease
* medications known to affect CNS function or impact physiologic parameters measured in the study
* significant visual impairment
* breath carbon monoxide (BCO) level of less than 10 ppm for smokers
* breath carbon monoxide (BCO) level of more than 5 ppm for non-smokers
* for heavy regular smokers: erratic smoking history (i.e. they must have smoked an average of 15 cigarettes daily for at least one year)
25 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oregon Health and Science University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Barry S. Oken
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barry Oken
Role: PRINCIPAL_INVESTIGATOR
Oregon Health and Science University
Laura Carim Todd
Role: PRINCIPAL_INVESTIGATOR
Oregon Health and Science University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oregon Health and Science University
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB6698
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.